or Try an Advanced Search...

    Technical Analysis for GHRS - GH Research PLC

    Grade Last Price % Change Price Change
    D 8.15 0.62% 0.05
    GHRS closed up 0.62 percent on Friday, November 1, 2024, on 1.93 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical GHRS trend table...
    Date Alert Name Type % Chg
    Shooting Star Candlestick Bearish 0.00%
    Lizard Bearish Bearish Day Trade Setup 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Doji - Bearish? Reversal 0.00%
    Wide Bands Range Expansion 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Fell Below 50 DMA Bearish 0.62%
    Wide Bands Range Expansion 0.62%
    Crossed Above 50 DMA Bullish -2.16%
    Older End-of-Day Signals for GHRS ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 22 hours ago
    Rose Above Upper Bollinger Band about 22 hours ago
    Rose Above 50 DMA about 22 hours ago
    Upper Bollinger Band Resistance about 22 hours ago
    Up 10% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    GHRS Chart by TradingView
    Basic chart:

    Profile

    GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that is being investigated in the Phase 2 part of an ongoing Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate that is in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was founded in 2018 and is based in Dublin, Ireland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Psychoactive Drugs Entheogens Treatment Resistant Depression Psychiatric And Neurological Disorders N Dimethyltryptamine

    Is GHRS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 9 GH Research (GHRS) Moves to Buy: Rationale Behind the Upgrade
    Sep 9 After Plunging -18.19% in 4 Weeks, Here's Why the Trend Might Reverse for GH Research (GHRS)
    Sep 3 GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
    Sep 3 GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
    Jun 2 GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans
    May 31 Psychedelic stocks mixed as FDA comments on MDMA therapy (update)
    May 10 Wall Street Analysts Predict a 166.89% Upside in GH Research (GHRS): Here's What You Should Know
    See more GHRS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.99
    52 Week Low 5.05
    Average Volume 50,399
    200-Day Moving Average 10.01
    50-Day Moving Average 8.07
    20-Day Moving Average 7.60
    10-Day Moving Average 8.01
    Average True Range 0.66
    RSI (14) 55.16
    ADX 16.16
    +DI 25.52
    -DI 16.08
    Chandelier Exit (Long, 3 ATRs) 7.04
    Chandelier Exit (Short, 3 ATRs) 7.98
    Upper Bollinger Bands 8.90
    Lower Bollinger Band 6.30
    Percent B (%b) 0.71
    BandWidth 34.12
    MACD Line 0.11
    MACD Signal Line -0.01
    MACD Histogram 0.1207
    Fundamentals Value
    Market Cap 423.97 Million
    Num Shares 52 Million
    EPS -0.79
    Price-to-Earnings (P/E) Ratio -10.32
    Price-to-Sales 0.00
    Price-to-Book 1.84
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.67
    Resistance 3 (R3) 9.79 9.40 9.41
    Resistance 2 (R2) 9.40 9.02 9.34 9.33
    Resistance 1 (R1) 8.78 8.78 9.09 8.66 9.24
    Pivot Point 8.39 8.39 8.55 8.33 8.39
    Support 1 (S1) 7.77 8.01 8.08 7.65 7.06
    Support 2 (S2) 7.38 7.77 7.32 6.97
    Support 3 (S3) 6.76 7.38 6.89
    Support 4 (S4) 6.64